Mother and daughter have been flying from Oklahoma to Los Angeles for one year for perispinal etanercept anti-TNF treatment at the INR® Los Angeles.
Please visit the website of the INR® for further information at www.nrimed.com.
Further Information
Journal Articles
Media Articles
International Press
About.com
- Etanercept Treatment for Alzheimer's Elicits Increased Attention
- Pioneer of Etanercept Treatment is Keynote Speaker for Drug Summit
- Etanercept Treatment for Alzheimer's Featured on National News Program
- Etanercept Research Continues to Spawn Hope, Criticism
- ICAD Review: Where Was the News Briefing About TNF?
More Articles
Pages
Links
More Information
Keyword Search
- Alzheimer Video News is a public service of the INR®
- Institute for Neurological Research, a private medical group, inc. 100 UCLA Medical Plaza Suites 205-210 Los Angeles CA 90095(310) 824-6199 Copyright ©2008, the Institute for Neurological Research® (INR®), a private medical group, inc., all rights reserved.
- Disclosure: Perispinal etanercept for Alzheimer's disease and other forms of dementia is a patented, off-label treatment method developed at the INR. U.S. patents 6,982,089 and 7,214,658, and additional issued and pending U.S. and foreign patents. These patents are assigned to TACT IP LLC.
- Alzheimer Video News is not medical advice nor should be treated as such.
- We believe it is the right of every individual to be fully informed on their quest for perfect health.
Terms of Use
Recent Posts
- Oklahoma mother and daughter discuss one year sustained results with perispinal etanercept
- Etanercept reaches cerebrospinal fluid in animal model
- Targeting Alzheimer's with Novel Therapeutics
- Children discuss improvement after perispinal etanercept for Alzheimer's
- Novelist Terry Pratchett on world wide quest for Alzheimer's treatment
- Excess TNF implicated in additional brain disorders
- Increasing scientific evidence supports an anti-TNF approach In Alzheimer's disease
- Merck drug fails to slow Alzheimer's symptoms
- Class action lawsuit filed against Elan
- Epilepsy Drug Demonstrates Improvement in Mouse Model of Alzheimer's Disease
Contact Us
Return to
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e55463e41b88330112793b4ade28a4
Listed below are links to weblogs that reference Sustained results through one year anti-TNF for AD:
Verify your Comment
Previewing your Comment
This is only a preview. Your comment has not yet been posted.
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Comments